Related Experiment Video
Updated: Aug 13, 2026
06:02
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
Heavy-chain diseases
1Department of Immuno-Hematology, Hôpital Saint-Louis, Paris, France. immuno-hem@chu-stlouis.fr
Hematology/Oncology Clinics of North America
|January 8, 2000
Insights
This review highlights the varied abnormalities in heavy chain deposition (HCD) proteins and associated lymphoproliferative disorders. Despite diversity, HCD-producing cells may originate from a single B cell precursor undergoing gene mutation.
Area of Science:
- Hematology
- Immunology
- Pathology
Background:
- Heavy chain deposition (HCD) disease involves the abnormal production of immunoglobulin proteins.
- Lymphoproliferative disorders associated with HCD exhibit diverse clinical and pathological features.
- Understanding the cellular origin of HCD-producing cells is crucial for disease pathogenesis.
Purpose of the Study:
- To review the structural and genetic diversity of HCD proteins.
- To examine the clinicopathologic spectrum of HCD-related lymphoproliferative disorders.
- To explore the potential common cellular precursor for HCD-producing cells.
Main Methods:
- Literature review of studies on HCD protein abnormalities.
- Analysis of clinicopathologic features in HCD-associated lymphoproliferative disorders.
- Review of B cell biology, focusing on immunoglobulin gene somatic mutation.
Main Results:
- HCD proteins display significant structural and genetic heterogeneity.
- Associated lymphoproliferative disorders present with a wide range of clinical manifestations and pathological findings.
- A common precursor cell, potentially a rare germinal center B cell, is proposed for HCD-producing cells.
Conclusions:
- The diversity in HCD protein abnormalities and disease features is substantial.
- Despite heterogeneity, a unified cellular origin from a somatically mutating B cell precursor is plausible.
- Further research into B cell development and mutation is warranted to fully elucidate HCD pathogenesis.
Abstract:
This review underscores the diversity of the structural and genetic abnormalities of HCD proteins and of the clinicopathologic features of the underlying lymphoproliferative disorders. Cells producing HCD may, however, all derive from a common normal precursor, which could be a rare B cell in the process of immunoglobulin gene somatic mutation within the germinal center.
Related Concept Videos
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...